rs80099330

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_000049.4(ASPA):​c.245T>C​(p.Met82Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000699 in 1,613,478 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0036 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00040 ( 3 hom. )

Consequence

ASPA
NM_000049.4 missense

Scores

2
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.282

Publications

1 publications found
Variant links:
Genes affected
ASPA (HGNC:756): (aspartoacylase) This gene encodes an enzyme that catalyzes the conversion of N-acetyl_L-aspartic acid (NAA) to aspartate and acetate. NAA is abundant in the brain where hydrolysis by aspartoacylase is thought to help maintain white matter. This protein is an NAA scavenger in other tissues. Mutations in this gene cause Canavan disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2008]
SPATA22 (HGNC:30705): (spermatogenesis associated 22) Predicted to be involved in regulation of meiotic cell cycle. Predicted to act upstream of or within several processes, including fertilization; gamete generation; and meiosis I cell cycle process. Predicted to be located in chromosome. [provided by Alliance of Genome Resources, Apr 2022]
SPATA22 Gene-Disease associations (from GenCC):
  • infertility disorder
    Inheritance: AR Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 48 curated pathogenic missense variants (we use a threshold of 10). The gene has 6 curated benign missense variants. Gene score misZ: 0.47868 (below the threshold of 3.09). Trascript score misZ: 1.2423 (below the threshold of 3.09). GenCC associations: The gene is linked to Canavan disease, mild Canavan disease, severe Canavan disease.
BP4
Computational evidence support a benign effect (MetaRNN=0.0061526597).
BP6
Variant 17-3481611-T-C is Benign according to our data. Variant chr17-3481611-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235503.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00361 (549/152270) while in subpopulation AFR AF = 0.0121 (501/41556). AF 95% confidence interval is 0.0112. There are 5 homozygotes in GnomAd4. There are 257 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000049.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASPA
NM_000049.4
MANE Select
c.245T>Cp.Met82Thr
missense
Exon 2 of 6NP_000040.1
ASPA
NM_001128085.1
c.245T>Cp.Met82Thr
missense
Exon 3 of 7NP_001121557.1
SPATA22
NM_001321337.2
c.-73-12213A>G
intron
N/ANP_001308266.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASPA
ENST00000263080.3
TSL:1 MANE Select
c.245T>Cp.Met82Thr
missense
Exon 2 of 6ENSP00000263080.2
ASPA
ENST00000456349.6
TSL:1
c.245T>Cp.Met82Thr
missense
Exon 3 of 7ENSP00000409976.2
ASPA
ENST00000858436.1
c.245T>Cp.Met82Thr
missense
Exon 3 of 7ENSP00000528495.1

Frequencies

GnomAD3 genomes
AF:
0.00360
AC:
548
AN:
152152
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.000929
AC:
233
AN:
250740
AF XY:
0.000642
show subpopulations
Gnomad AFR exome
AF:
0.0131
Gnomad AMR exome
AF:
0.000522
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000396
AC:
579
AN:
1461208
Hom.:
3
Cov.:
31
AF XY:
0.000315
AC XY:
229
AN XY:
726890
show subpopulations
African (AFR)
AF:
0.0140
AC:
469
AN:
33456
American (AMR)
AF:
0.000537
AC:
24
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26114
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39618
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86156
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.000532
AC:
3
AN:
5640
European-Non Finnish (NFE)
AF:
0.0000405
AC:
45
AN:
1111780
Other (OTH)
AF:
0.000613
AC:
37
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
31
61
92
122
153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00361
AC:
549
AN:
152270
Hom.:
5
Cov.:
32
AF XY:
0.00345
AC XY:
257
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.0121
AC:
501
AN:
41556
American (AMR)
AF:
0.00255
AC:
39
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68026
Other (OTH)
AF:
0.00380
AC:
8
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
26
53
79
106
132
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00127
Hom.:
5
Bravo
AF:
0.00412
ESP6500AA
AF:
0.0116
AC:
51
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00126
AC:
153
Asia WGS
AF:
0.00202
AC:
7
AN:
3476
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Spongy degeneration of central nervous system (3)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
2.2
DANN
Benign
0.87
DEOGEN2
Uncertain
0.59
D
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.24
T
MetaRNN
Benign
0.0062
T
MetaSVM
Uncertain
0.020
D
MutationAssessor
Benign
-0.55
N
PhyloP100
-0.28
PrimateAI
Benign
0.32
T
PROVEAN
Benign
0.12
N
REVEL
Benign
0.16
Sift
Benign
0.57
T
Sift4G
Benign
0.59
T
Polyphen
0.0010
B
Vest4
0.092
MVP
0.72
MPC
0.078
ClinPred
0.00042
T
GERP RS
-3.3
Varity_R
0.13
gMVP
0.46
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80099330; hg19: chr17-3384905; COSMIC: COSV99036547; API